Lipoxin A4 Activates Nrf2 Pathway and Ameliorates Cell Damage in Cultured Cortical Astrocytes Exposed to Oxygen-Glucose Deprivation/Reperfusion Insults
- PMID: 25702137
- DOI: 10.1007/s12031-015-0525-6
Lipoxin A4 Activates Nrf2 Pathway and Ameliorates Cell Damage in Cultured Cortical Astrocytes Exposed to Oxygen-Glucose Deprivation/Reperfusion Insults
Abstract
Lipoxin A4 (LXA4), a potent antioxidant and anti-inflammation mediator, protects brains against cerebral ischemia/reperfusion (I/R) injury in vivo. However, few reports concern its function on astrocytes during cerebral I/R injury. The pathogenesis of cerebral I/R injury involves oxidative stress caused by reactive oxygen species (ROS). Upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) is generally considered to reduce oxidative stress. Nrf2 can induce heme oxygenase-1 (HO-1) expression and glutathione (GSH) release to combat increased oxidative stress. We investigated the effects of LXA4 on astrocytic cell damage, the production of ROS, and Nrf2 pathway, especially on HO-1 expression and GSH release in cultured cortical astrocytes exposed to oxygen-glucose deprivation (OGD)/recovery (OGDR) insults. Primary astrocytes were subjected to a 4-h OGD, followed by 8-h recovery. Cell viability, the production of ROS, and GSH release were measured. Furthermore, Nrf2, HO-1, and p62 expression levels were determined by Western blot. Moreover, Nrf2 location was studied by immunofluorescence staining. Treatment of LXA4 attenuates OGDR-induced cell damage and the production of ROS in a concentration-related manner. LXA4 induced Nrf2 expression and its nuclear translocation, as well as HO-1 expression and GSH release. Moreover, LXA4 induced the excess p62 accumulation. These results indicate that LXA4 can effectively protect against OGDR-induced cell damage in astrocytes, and activation of Nrf2 pathway to reduce oxidative stress may be involved in its protective effects. p62 accumulation induced by LXA4 may be closely related to Nrf2 activation.
Similar articles
-
Lipoxin A4 ameliorates cerebral ischaemia/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2.Neurol Res. 2013 Nov;35(9):968-75. doi: 10.1179/1743132813Y.0000000242. Epub 2013 Jul 22. Neurol Res. 2013. PMID: 23880501
-
Lipoxin A4 Preconditioning Attenuates Intestinal Ischemia Reperfusion Injury through Keap1/Nrf2 Pathway in a Lipoxin A4 Receptor Independent Manner.Oxid Med Cell Longev. 2016;2016:9303606. doi: 10.1155/2016/9303606. Epub 2016 Jun 7. Oxid Med Cell Longev. 2016. PMID: 27375835 Free PMC article.
-
Posttreatment with 11-Keto-β-Boswellic Acid Ameliorates Cerebral Ischemia-Reperfusion Injury: Nrf2/HO-1 Pathway as a Potential Mechanism.Mol Neurobiol. 2015 Dec;52(3):1430-1439. doi: 10.1007/s12035-014-8929-9. Epub 2014 Oct 28. Mol Neurobiol. 2015. PMID: 25452227
-
Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.Mol Neurobiol. 2017 Oct;54(8):6006-6017. doi: 10.1007/s12035-016-0111-0. Epub 2016 Sep 30. Mol Neurobiol. 2017. PMID: 27696223 Review.
-
Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.Mol Neurobiol. 2011 Oct;44(2):192-201. doi: 10.1007/s12035-011-8181-5. Epub 2011 Apr 19. Mol Neurobiol. 2011. PMID: 21499987 Free PMC article. Review.
Cited by
-
A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule.Inflamm Res. 2024 Jul;73(7):1099-1106. doi: 10.1007/s00011-024-01885-6. Epub 2024 Apr 26. Inflamm Res. 2024. PMID: 38668877 Review.
-
BML-111 inhibit H2O2-induced pyroptosis and osteogenic dysfunction of human periodontal ligament fibroblasts by activating the Nrf2/HO-1 pathway.BMC Oral Health. 2024 Jan 8;24(1):40. doi: 10.1186/s12903-023-03827-w. BMC Oral Health. 2024. PMID: 38191432 Free PMC article.
-
Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease.Ann Med. 2023;55(2):2284890. doi: 10.1080/07853890.2023.2284890. Epub 2023 Dec 1. Ann Med. 2023. PMID: 38039549 Free PMC article. Review.
-
Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms.Front Immunol. 2023 Jun 14;14:949407. doi: 10.3389/fimmu.2023.949407. eCollection 2023. Front Immunol. 2023. PMID: 37388729 Free PMC article.
-
Lipoxin alleviates oxidative stress: a state-of-the-art review.Inflamm Res. 2022 Nov;71(10-11):1169-1179. doi: 10.1007/s00011-022-01621-y. Inflamm Res. 2022. PMID: 35947143 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical